Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on metal free catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover a cost-effective, metal-free synthesis method for trifluoromethyl-1,2,4-triazine compounds. Eliminate heavy metal catalysts and nitrogen protection to reduce production costs and supply chain risks.
Discover a cost-effective, metal-free method for 2-pyrrolidone synthesis with >85% yield. Eliminate transition metal risks and scale efficiently for drug development.
Discover a high-yield, silver-salt-free synthesis for xianglanoside intermediates. Reduce production costs and eliminate column chromatography for stable supply chains.
Discover a cost-effective, non-toxic synthesis method for 1,2-vicinal diols with >85% yield. Eliminate heavy metal catalysts and scale-up risks for pharmaceutical intermediates.
Solve supply chain risks with this metal-free 2-trifluoromethyl quinoline synthesis. No catalysts, air-tolerant, high yield. Scale to 100MT/yr with NINGBO INNO PHARMCHEM.
Solve high-cost catalyst issues in indoloisoquinolinone synthesis. This metal-free, visible-light method offers 60-72% yield with easy scale-up for drug development.
Solve high-cost N-difluoromethylation challenges with room-temperature, metal-free process. 90% yield, broad substrate scope. Scale to 100MT/yr.
Discover how visible light-induced, metal-free synthesis of 3-aryl-2H-indazoles reduces production costs and safety risks. Ideal for API manufacturing and drug development.
Solve multi-step synthesis challenges with metal-free, high-yield imidazo[1,2-c]quinazolin-3(2H)-one production. Reduce costs and environmental risks for pharma supply chains.
Eliminate metal catalysts and harsh conditions in 2-trifluoromethyl quinoline synthesis. Our green, scalable method ensures high purity and supply chain stability for API manufacturing.
Solve supply chain risks with metal-free, high-yield synthesis of trifluoromethyl selenium azaspiro[4,5]-tetraenone. Reduce costs and ensure 99% purity for drug development.
Solve supply chain risks with metal-free synthesis of trifluoromethyl selenium azaspiro[4,5]-tetraenone. Eliminate heavy metal catalysts, reduce costs, and ensure GMP compliance for pharma intermediates.
Eliminate anhydrous/oxygen-free requirements in 1,2,4-triazole synthesis. Scale to gram-level with biomass-derived glucose. Reduce production costs by 30% for drug development.
Solve supply chain risks with this one-step quinoline-4(1H)-one synthesis. No CO gas, high yield, and broad substrate tolerance for API manufacturing.
Solve low-yield & heavy metal issues in pyrido[1,2-a][1,3,5]-triazin-4-one synthesis. Scale to 100MT/yr with anhydrous-free, cost-effective CDMO solutions.
Solve high-cost N-difluoromethylation challenges with room-temperature, metal-free process. 90% yield, broad functional group tolerance. Contact for CDMO solutions.
Discover a novel metal-free synthesis of 1,2,4-triazolyl arylamines with no anhydrous conditions. Reduce production costs and supply chain risks for drug development.
Discover how metal-free photoredox catalysis enables high-yield, enantioselective synthesis of chiral thiochroman-4-ketones for anticancer drug development. Reduce supply chain risks and GMP compliance costs.
Discover how metal-free photoredox catalysis enables high-yield, enantioselective synthesis of chiral chroman-4-ones for anticancer drug development. Reduce supply chain risks and improve purity.
Discover how symmetric bispiperidine metal complexes solve multi-step synthesis challenges in API manufacturing with >99% selectivity and reduced supply chain risks for pharma R&D and production teams.